NCNA NuCana PLC

USD 0.26 -0.05 -15.226606
Icon

NuCana PLC (NCNA) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.26

-0.05 (-15.23)%

USD 0.02B

1.30M

N/A

N/A

Icon

NCNA

NuCana PLC (USD)
COMMON STOCK | NSD
USD 0.26
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.02B

N/A

USD 0.26

NuCana PLC (NCNA) Stock Forecast

N/A

Based on the NuCana PLC stock forecast from 0 analysts, the average analyst target price for NuCana PLC is not available over the next 12 months. NuCana PLC’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of NuCana PLC is Slightly Bearish, which is based on 3 positive signals and 5 negative signals. At the last closing, NuCana PLC’s stock price was USD 0.26. NuCana PLC’s stock price has changed by -10.25% over the past week, -20.80% over the past month and -69.52% over the last year.

No recent analyst target price found for NuCana PLC
No recent average analyst rating found for NuCana PLC

Company Overview NuCana PLC

NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of medicines to treat patients with cancer. The company applies its ProTide technology to transform prescribed chemotherapy agents and nucleoside analogs into medicines. The company, through its te...Read More

https://www.nucana.com

3 Lochside Way, Edinburgh, United Kingdom, EH12 9DT

28

December

USD

USA

Adjusted Closing Price for NuCana PLC (NCNA)

Loading...

Unadjusted Closing Price for NuCana PLC (NCNA)

Loading...

Share Trading Volume for NuCana PLC Shares

Loading...

Compare Performance of NuCana PLC Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for NCNA

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To NuCana PLC (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
NVO
Novo Nordisk A/S +0.35 (+0.27%) USD554.45B 46.01 4.80

ETFs Containing NCNA

Symbol Name NCNA's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About NuCana PLC (NCNA) Stock

Stock Target Advisor's fundamental analysis for NuCana PLC's stock is Slightly Bearish.

Unfortunately we do not have enough data on NCNA's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on NCNA's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on NCNA's stock to indicate if its overvalued.

The last closing price of NCNA's stock was USD 0.26.

The most recent market capitalization for NCNA is USD 0.02B.

Unfortunately we do not have enough analyst data on NCNA's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains NuCana PLC's stock.

As per our most recent records NuCana PLC has 28 Employees.

NuCana PLC's registered address is 3 Lochside Way, Edinburgh, United Kingdom, EH12 9DT. You can get more information about it from NuCana PLC's website at https://www.nucana.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...